Department of Internal Medicine III, Division of Nephrology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Abteilung für Innere Medizin, Krankenhaus der Barmherzigen Brüder, Linz, Austria.
Intensive Care Med. 2015 Nov;41(11):1941-9. doi: 10.1007/s00134-015-3989-5. Epub 2015 Aug 22.
More than 20 years ago we reported an analysis of a case series of elderly critically ill patients with acute kidney injury (AKI)--then termed acute renal failure. At that time, AKI was regarded as a "simple" complication, but has since undergone a fundamental change and actually has become one of the central syndromes in the critically ill patient.
We have analyzed elderly patients above 65 years of age with an AKI defined as serum creatinine above 3 mg/dl corresponding to modern KDIGO stage 3, most of them requiring renal replacement therapy (RRT). Using an extremely complete data set the diagnosis differentiated the underlying disease entity, the dominant cause of AKI, acute and chronic risk factors (comorbidities). Special aspects such as severity of disease, early AKI at admission versus late AKI, early versus later start of RRT, AKI not treated by RRT in spite of indication for RRT, various measures of short-term and long-term prognosis, renal outcome, patients dying with resolved AKI, and causes of death were evaluated.
Crude mortality was 61% which corresponds to modern studies with gross variation among the different subgroups. Age per se was not a determinant of survival either within the group of elderly patients or as compared to younger age groups. Despite an increase in mean age and disease severity during the observation period prognosis improved. A total of 17% of patients developed a chronic kidney disease. Long-term survival as compared to the general population was low.
A look back at the last two decades illustrates a remarkable evolution or rather metamorphosis of a syndrome. AKI has evolved as a central syndrome in intensive care patients, a systemic disease process associated with multiple systemic sequels and extra-renal organ injury and exerting a pronounced effect on the course of disease and short- and long-term prognosis not only of the patient but also of the kidney. Moreover, the "non-renal-naïve" elderly patient with multiple comorbidities has become the most frequent ICU patient in industrialized nations.
20 多年前,我们报告了一组老年危重症急性肾损伤(AKI)患者的病例系列分析——当时称为急性肾衰竭。当时,AKI 被认为是一种“简单”的并发症,但此后发生了根本性变化,实际上已成为危重症患者的中心综合征之一。
我们分析了年龄在 65 岁以上的 AKI 患者,定义为血清肌酐超过 3mg/dl,相当于现代 KDIGO 分期 3 期,大多数患者需要肾脏替代治疗(RRT)。使用极其完整的数据集,该诊断区分了基础疾病实体、AKI 的主要原因、急性和慢性危险因素(合并症)。特殊方面,如疾病严重程度、入院时的早期 AKI 与晚期 AKI、早期与晚期开始 RRT、尽管有 RRT 指征但未接受 RRT 的 AKI、短期和长期预后的各种措施、肾脏结局、因 AKI 缓解而死亡的患者以及死亡原因都进行了评估。
粗死亡率为 61%,与现代研究相比,不同亚组之间存在很大差异。年龄本身并不是老年患者组或与年轻患者组生存的决定因素。尽管在观察期间,平均年龄和疾病严重程度有所增加,但预后有所改善。共有 17%的患者发展为慢性肾脏病。与一般人群相比,长期生存率较低。
回顾过去 20 年,说明了一种综合征的显著演变或转变。AKI 已作为重症监护患者的中心综合征演变,是一种与多种全身后遗症和肾外器官损伤相关的全身性疾病过程,对疾病过程和短期及长期预后产生显著影响,不仅对患者,而且对肾脏也有影响。此外,患有多种合并症的“非肾脏初治”老年患者已成为工业化国家最常见的 ICU 患者。